Adagio Medical Holdings, Inc. - 10-Q Filing
Adagio Medical Holdings filed its Q1 2026 10-Q report with the SEC, disclosing financial and operational details for the quarter ended March 31, 2026. The filing includes updates on convertible warrants, fair value measurements, equity compensation plans, supplier concentration risks, and related-party agreements such as a shared services agreement with Fjord Ventures.
Tickers: $ADGM